ODONATE THERAPEUTICS INC's ticker is ODT and the CUSIP is 676079106. A total of 70 filers reported holding ODONATE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $0 | – | 216 | +1100.0% | 0.00% | – |
| Q3 2021 | $0 | – | 18 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 18 | -98.7% | 0.00% | – |
| Q1 2021 | $4,000 | -98.9% | 1,344 | -92.9% | 0.00% | – |
| Q4 2020 | $363,000 | +24.3% | 18,879 | -13.1% | 0.00% | – |
| Q3 2020 | $292,000 | -64.6% | 21,718 | +11.6% | 0.00% | – |
| Q2 2020 | $825,000 | +114.8% | 19,468 | +40.0% | 0.00% | – |
| Q1 2020 | $384,000 | -15.2% | 13,910 | -0.2% | 0.00% | – |
| Q4 2019 | $453,000 | +18.9% | 13,942 | -4.7% | 0.00% | – |
| Q3 2019 | $381,000 | +231.3% | 14,630 | +368.6% | 0.00% | – |
| Q2 2019 | $115,000 | +36.9% | 3,122 | -17.9% | 0.00% | – |
| Q1 2019 | $84,000 | +55.6% | 3,801 | -0.2% | 0.00% | – |
| Q4 2018 | $54,000 | -27.0% | 3,810 | -0.7% | 0.00% | – |
| Q3 2018 | $74,000 | -7.5% | 3,835 | +5.6% | 0.00% | – |
| Q2 2018 | $80,000 | -2.4% | 3,631 | -6.1% | 0.00% | – |
| Q1 2018 | $82,000 | – | 3,868 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 4,207,086 | $5,553,000 | 0.28% |
| Samsara BioCapital, LLC | 700,421 | $925,000 | 0.23% |
| Hennion & Walsh Asset Management, Inc. | 69,264 | $91,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 384,995 | $506,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 43,752 | $58,000 | 0.00% |
| SIMPLEX TRADING, LLC | 2,000 | $2,000 | 0.00% |
| Newbridge Financial Services Group, Inc. | 47 | $0 | 0.00% |
| BESSEMER GROUP INC | 230 | $0 | 0.00% |